MegaPro Biomedical Co., Ltd (6827.TWO)
TWD 10.05
(-17.28%)
TWD 10.05
(-17.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -110.63 Million TWD | -13.64% |
| 2022 | -97.35 Million TWD | -19.29% |
| 2021 | -81.61 Million TWD | 43.05% |
| 2020 | -143.31 Million TWD | 19.64% |
| 2019 | -178.33 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -68.26 Million TWD | -20.77% |
| 2023 Q4 | -56.52 Million TWD | -5.04% |
| 2023 Q2 | -53.81 Million TWD | -31.19% |
| 2023 FY | - TWD | -13.64% |
| 2022 FY | - TWD | -19.29% |
| 2022 Q4 | -41.02 Million TWD | 0.0% |
| 2021 FY | - TWD | 43.05% |
| 2020 FY | - TWD | 19.64% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -139.248% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 128.109% |
| Level Biotechnology Inc. | 98.7 Million TWD | 212.091% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -147.297% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -53.419% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -338.466% |
| GlycoNex Incorporation | -126.82 Million TWD | 12.765% |
| VBI | -6.97 Million TWD | -1486.89% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 23.005% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 607.281% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -524.157% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -6.778% |
| Visgeneer Inc. | 973 Thousand TWD | 11470.812% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 67.41% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 111.814% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 210.819% |
| Neith Corporation | -33.61 Million TWD | -229.182% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 88.837% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -6269.488% |
| Enimmune corporation | -228.96 Million TWD | 51.679% |
| TaiRx, Inc. | -208.64 Million TWD | 46.973% |
| CHO Pharma, Inc. | -277.73 Million TWD | 60.164% |
| EirGenix Inc. | -664.4 Million TWD | 83.348% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 249.705% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 260.013% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 89.674% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 2.182% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 417.579% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -77.472% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -320.677% |
| RBC Bioscience Corporation | 36.54 Million TWD | 402.728% |
| BiOptic Inc. | 65.03 Million TWD | 270.113% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 83.788% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -235.206% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -101.471% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 125.519% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -38.173% |
| NaviFUS Corp. | -55.79 Million TWD | -98.294% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -566.574% |
| Sinew Pharma Inc. | -163.63 Million TWD | 32.386% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -79.899% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 157.504% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 51.192% |
| AP Biosciences Inc | -325.51 Million TWD | 66.011% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 89.409% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -208.648% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 479.808% |
| Intech Biopharm Corporation | -219.58 Million TWD | 49.615% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 83.59% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -146.13% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 31.22% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 116.878% |
| TCI GENE Inc. | 25.98 Million TWD | 525.842% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 61.013% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 24.205% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 898.83% |
| PharmaEngine, Inc. | 347.3 Million TWD | 131.856% |
| Savior Lifetec Corporation | 219.6 Million TWD | 150.38% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 164.239% |
| OBI Pharma, Inc. | -855.08 Million TWD | 87.061% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -19.527% |
| Acepodia, Inc. | -764.51 Million TWD | 85.528% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 75.953% |